Resolution regarding reduction of the share capital without cancellation of shares The extraordinary general meeting in Medivir Aktiebolag (publ) on 13...
Read moreStockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that a presentation entitled “Phase I study of the novel pro-drug...
Read moreStockholm — Medivir AB (publ) (Nasdaq Stockholm: MVIR) today announced that it has entered into an exclusive licensing agreement, through which...
Read more